These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7677224)

  • 1. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis.
    Mendonca SC; De Luca PM; Mayrink W; Restom TG; Conceicao-Silva F; Da-Cruz AM; Bertho AL; Da Costa CA; Genaro O; Toledo VP
    Am J Trop Med Hyg; 1995 Aug; 53(2):195-201. PubMed ID: 7677224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis.
    De Luca PM; Mayrink W; Alves CR; Coutinho SG; Oliveira MP; Bertho AL; Toledo VP; Costa CA; Genaro O; Mendonça SC
    Vaccine; 1999 Mar; 17(9-10):1179-85. PubMed ID: 10195630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis.
    De Luca PM; Mayrink W; Pinto JA; Coutinho SG; Santiago MA; Toledo VP; Costa CA; Genaro O; Reis AB; Mendonça SC
    Acta Trop; 2001 Dec; 80(3):251-60. PubMed ID: 11700183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production.
    Castés M; Blackwell J; Trujillo D; Formica S; Cabrera M; Zorrilla G; Rodas A; Castellanos PL; Convit J
    Vaccine; 1994 Aug; 12(11):1041-51. PubMed ID: 7975845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica.
    Maasho K; McMahon-Pratt D; Raita J; Raud M; Britton S; Soong L; Akuffo H
    Clin Exp Immunol; 2003 May; 132(2):316-22. PubMed ID: 12699423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia.
    Silveira FT; Blackwell JM; Ishikawa EA; Braga R; Shaw JJ; Quinnell RJ; Soong L; Kima P; McMahon-Pratt D; Black GF; Shaw MA
    Parasite Immunol; 1998 Jan; 20(1):19-26. PubMed ID: 9491414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.
    Pinto EF; de Mello Cortezia M; Rossi-Bergmann B
    Vaccine; 2003 Sep; 21(25-26):3534-41. PubMed ID: 12922080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
    Walker PS; Scharton-Kersten T; Rowton ED; Hengge U; Bouloc A; Udey MC; Vogel JC
    Hum Gene Ther; 1998 Sep; 9(13):1899-907. PubMed ID: 9741428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.
    Telino E; De Luca PM; Matos DC; Azeredo-Coutinho RB; Meirelles MN; Conceição-Silva F; Schubach A; Mendonça SC
    Clin Exp Immunol; 2006 Feb; 143(2):338-44. PubMed ID: 16412059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.
    Mendes-Aguiar Cde O; Gomes-Silva A; Nunes E; Pereira-Carvalho R; Nogueira RS; Oliveira-Neto Mde P; Bertho AL; Da-Cruz AM
    Clin Exp Immunol; 2009 Sep; 157(3):377-84. PubMed ID: 19664146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunopathology of American tegumentary leishmaniasis].
    Castés M; Tapia FJ
    Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and Functional Profiles of Antigen-Specific CD4
    Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC
    Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
    Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
    Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.
    Kemp M; Handman E; Kemp K; Ismail A; Mustafa MD; Kordofani AY; Bendtzen K; Kharazmi A; Theander TG
    FEMS Immunol Med Microbiol; 1998 Mar; 20(3):209-18. PubMed ID: 9566492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis.
    Haberer JE; Da-Cruz AM; Soong L; Oliveira-Neto MP; Rivas L; McMahon-Pratt D; Coutinho SG
    Infect Immun; 1998 Jul; 66(7):3100-5. PubMed ID: 9632572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis.
    Carvalho AM; Magalhães A; Carvalho LP; Bacellar O; Scott P; Carvalho EM
    BMC Infect Dis; 2013 Nov; 13():529. PubMed ID: 24206576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis.
    Bittar RC; Nogueira RS; Vieira-Gonçalves R; Pinho-Ribeiro V; Mattos MS; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Mem Inst Oswaldo Cruz; 2007 Aug; 102(5):625-30. PubMed ID: 17710308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.